National Blood Sector Research and Development Program – Round 4

Overview

The National Blood Sector Research and Development Program (Program) forms an important component of the National Blood Authority’s (NBA) blood sector research and development framework and aims to facilitate world-class research and development in Australia that contributes to optimising the use, management and administration of blood products, and improve patient outcomes.    The Program is focussed on the following research areas:   Patient Blood Management (PBM) evidence gaps, as identified in the NBA’s PBM Guidelines, and Efficient and effective use of immunoglobulin (Ig) products, as highlighted through the Ig Governance Program.  No more than $1.275 million is available under Round 4 of the Program for single or multiple year projects.   Grants are offered under 3 categories as outlined below: Project Grants, typically $30,000 to $150,000 per year to be expended over a period of up to 3 years. Applications should be for an entire, discrete research project proposal.  Seed Grants, typically under $50,000 to be expended over 1 year.  Applications for seed funding should be for early stages of innovative new research, or for effort generation of preliminary data needed to support future grant applications. Scholarships, typically $25,000 to $30,000 to be expended over 1 year.  Scholarship grants are intended to support medical researchers in the attainment of a PhD or Master’s degree or postdoctoral research fellow research. Application forms are available on the NBA Website at   https://www.blood.gov.au/research-and-development